Clinical Trial Update: Population Pharmacokinetic-pharmacodynamic (PK-PD) Modeling of Co-administered Gabapentin in Neuropathic Pain [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update reporting population PK-PD modeling of co-administered gabapentin in patients with post-traumatic neuropathic pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Neuropathic Pain

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: Uppsala University | Conditions: Post-traumatic Neuropathic Pain | Phase 2 | Status: COMPLETED